Vestal Point Capital »

Dbv Technologies Sa shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Dbv Technologies Sa (DBVT) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Dbv Technologies Sa

Tip: Access up to 7 years of quarterly data

All positions including Dbv Technologies Sa held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dbv Technologies Sa by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.8M 300k 19.17

More positions owned by Vestal Point Capital

Abivax SA Sponsored Ads (ABVX)
Invesco QQQ Trust Series 1 Unit Ser 1 Put Option (QQQ)
Arcellx Common Stock (ACLX)
Terns Pharmaceuticals (TERN)
BioMarin Pharmaceutical (BMRN)
Globus Medical Cl A (GMED)
Nurix Therapeutics (NRIX)
Alcon Ord Shs (ALC)
Dex (DXCM)
Merck & Co (MRK)
Taysha Gene Therapies Com Shs (TSHA)
Abbott Laboratories (ABT)
Immatics NV SHS (IMTX)
Tyra Biosciences (TYRA)
Bicara Therapeutics (BCAX)

View all positions for Vestal Point Capital

Top funds holding Dbv Technologies Sa

Artisan Partners Limited Partnership
Vivo Capital
Siren
Baker Bros. Advisors
MPM Oncology Impact Management
Yiheng Capital
Octagon Capital Advisors
Ikarian Capital
Schonfeld Strategic Advisors
Patient Square Capital
Adage Capital Partners GP
Millennium Management
Vestal Point Capital
UBS Group
New York State Common Retirement Fund

View all funds holding Dbv Technologies Sa